4 U.S. companies will pay $26 billion to settle claims they fueled the opioid crisis
The companies, including Johnson & Johnson and McKesson, will admit no wrongdoing. Billions of dollars in payouts will fund drug treatment and harm reduction programs.
Four of the largest U.S. corporations have agreed to pay roughly $26 billion to settle a tsunami of lawsuits linked to claims their business practices helped fuel the deadly opioid crisis.
Johnson & Johnson, the consumer products and health giant which manufactured generic opioid medications, will contribute $5 billion to the settlement.
The company announced in 2020 it would get out of the prescription opioid business in the U.S. altogether.
Three massive drug wholesalers — AmerisourceBergen, Cardinal Health and
